Joel Beatty is a Baird Senior Research Analyst covering Biotechnology. Before joining Baird in 2021, he spent eight years at Citigroup, most recently as a director in equity research. In 2017, he received the 2nd-highest vote count in the Institutional Investor SMid Biotech Rising Star survey. Before equity research, he was a practicing physician and board certified in Preventive Medicine. Joel received MD, MPH and MBA degrees from the University at Buffalo.